Cited by 48Inflammatory Bowel DiseaseGut microbiota and healthAnorectal Disease Treatments and Outcomes

Efficacy and safety of fecal microbiota transplantation for treating patients with ulcerative colitis: A systematic review and meta-analysis

Zhao, Hai Lan, Chen, Shu Zhen, Xu, Hao Ming, Zhou, You Lian, He, Jie, Huang, Hong Li, Xu, Jing, Nie, Yu Qiang·2020·Journal of Digestive Diseases

Abstract

Objectives To assess the effect of donor selection, stool procedures and pretreatment with antibiotics on the efficacy and safety of fecal microbiota transplantation (FMT)‐treated ulcerative colitis (UC). Methods A systematic review and meta‐analysis was conducted including studies on UC treated with FMT as the primary therapeutic agent published up to June 30, 2020. Primary end‐point data included clinical remission (CR) or CR combined with endoscopic remission. Results A total of 37 studies (seven random controlled trials [RCTs], five controlled and 25 uncontrolled cohort studies) and 959 patients with UC were enrolled. In controlled cohort studies and RCTs, FMT had a significantly greater benefit than placebo (pooled odds ratio [P‐OR] 3.392, 95% CI 2.196‐5.240, P < 0.001), with no heterogeneity (I2 = 0%). Furthermore, administration of FMT via the lower gastrointestinal (GI) tract was more effective in achieving CR than via the upper GI tract (44.3% vs 31.7%). The remission rate was also higher when the total stool dosage was over 275 g compared with less than 275 g (51.9% vs 29.5%). Overall, the incidence of serious adverse events of FMT was 5.9%. There was no significant difference between single and multiple donors, fresh and frozen stool sample used, and whether or not antibiotic pretreatment was administered before FMT. Conclusion FMT administration via the lower GI tract and using higher dosage appear to be effective and safe in inducing remission of active UC.

Integrity signals

Registry

Crossref · 10.1111/1751-2980.12933

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • After positive outcomes for CDI, FMT has been investigated for a number of chronic disorders associated with dysbiosis, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), metabolic syndrome (MetS), neuropsychiatric disorders, and others.

    “After positive outcomes for CDI, FMT has been investigated for a number of chronic disorders associated with dysbiosis, including inflammatory bowel disease (IBD), 35 irritable bowel syndrome (IBS), 36 metabolic syndrome (MetS), 37 neuropsychiatric disorders, 38 andothers.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zhao, H. L., Chen, S. Z., Xu, H. M., Zhou, Y. L., He, J., Huang, H. L., Xu, J., & Nie, Y. Q.
Affiliations
Guangzhou First People's Hospital (CN)
Corresponding author
Nie, Yu Qiang
Venue
Journal of Digestive Diseases
Publisher
Wiley
Published
2020-10
Volume
21
Issue
10
Pages
534-548
ISSN
  • 1751-2972 (ISSN-L)
  • 1751-2980
OpenAlex
W3037354716
Cited by
48
References
51
Citations by year
2026: 6 · 2025: 8 · 2024: 10 · 2023: 8 · 2022: 8 · 2021: 6 · 2020: 1
FWCI
0.82
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Digestive Diseases (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Surgery › Anorectal Disease Treatments and Outcomes
Keywords
fecal microbiota transplantation, ulcerative colitis, clinical remission, endoscopic remission, donor selection, antibiotic pretreatment, adverse events
MeSH terms
Fecal Microbiota Transplantation, Colitis, Ulcerative, Humans, Remission Induction, Randomized Controlled Trials as Topic, Treatment Outcome, Controlled Clinical Trials as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review